Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Evotec
Evotec
Activities:
Research & Development
Cleaning
Pharmaceutical
X
LinkedIn
Trending Articles
Agilent boosts contract manufacturing capabilities with acquisition of BIOVECTRA
The CDMO acquisition will bolster Agilent's end-to-end production capabilities in a number of popular therapeutics, including GLP-1 medications and ADCs
KBI Biopharma extends contract with a big pharma giant after a successful FDA inspection
The contract has been renewed and extended until at least 2029, and will now include the purchase of two therapeutic products
Currax to build novel anti-obesity treatment production facility amidst GLP-1 supply issues
The manufacturing facility will be dedicated to the production of anti-obesity drug Contrave, and will double its output in the EU and EEA
New FAIRY viral assay could 'revolutionise' the response to future pandemics
The assay, which can detect the infectiousness of a virus in a matter of minutes, offers a quicker and cheaper alternative to the standard cell culture approach
New advice from BOLA and Labtex on cleaning and handling of PTFE products after use
The companies share: "Abrasive scouring agents may result in a milkiness of the vessels made of PFA and FEP. You may use all neutral detergents (pH 7). For higher contamination...
Upcoming event
ISPE Singapore
28-30 August 2024 | Conference and exhibition | Singapore
See all
Related Content
Research & Development
SynaptixBio and Evotec collaborate to develop novel antisense oligonucelotides for H-ABC
The companies will look to discover novel antisense oligonucleotides targeting mutant TUBB4A for the treatment of H-ABC
Manufacturing
Titian and Evotec sign three-year agreement for sample management platform
The two companies have entered into an agreement that means Titian's software user licences can enable rapid deployment across new Evotec stites
Pharmaceutical
Evotec agrees to give US Merck access to facility of the future
MSD has paid $15m to gain access to Just–Evotec Biologics’ J.POD Washington facility that conducts small, intensified bioprocessing operations housed inside autonomous cleanrooms
Finance
Evotec acquires US biotech Just Biotherapeutics for $90 million
The US$90 million for the German company to make the acquisition includes the potential performance-based earn-out components expected within the next three years
Research & Development
Pharma giants join £9.5 million dementia drug discovery collaboration
Johnson & Johnson Innovation, Takeda and Evotec have joined The Dementia Consortium
Research & Development
Galapagos expands fibrosis portfolio
Fibrosis small molecule programme has been announced as the focus of a partnership between Galapagos and Evotec
Research & Development
Evotec and ABIVAX collaborate to develop novel antiviral agents
Evotec and ABIVAX have announced a strategic collaboration to discover and develop novel treatments for multiple viral infectious diseases
Subscribe now